IDEAYA Biosciences Inc: About 67% Eye Preservation Rate With Darovasertib Monotherapy Neoadjuvant Uveal Melanoma Treatment
IDEAYA Biosciences Inc:Darovasertib 单一疗法新辅助葡萄膜黑色素瘤治疗的眼睛保全率约为 67%
IDEAYA Biosciences Inc: About 67% Eye Preservation Rate With Darovasertib Monotherapy Neoadjuvant Uveal Melanoma Treatment
IDEAYA Biosciences Inc:Darovasertib 单一疗法新辅助葡萄膜黑色素瘤治疗的眼睛保全率约为 67%
使用浏览器的分享功能,分享给你的好友吧